World Journal of Dentistry

Register      Login

VOLUME 14 , ISSUE 9 ( September, 2023 ) > List of Articles


Comparative Study between 1% Metformin and 1% Alendronate Gel in the Treatment of Infrabony Defects: A Randomized Controlled Trial

Dipika Mitra, Chaitrali Lakade, Ankit Desai, Prachi Gurav, Bela Khobragade

Keywords : Alendronate, Bone regeneration, Metformin, Periodontal regeneration, Periodontitis

Citation Information : Mitra D, Lakade C, Desai A, Gurav P, Khobragade B. Comparative Study between 1% Metformin and 1% Alendronate Gel in the Treatment of Infrabony Defects: A Randomized Controlled Trial. World J Dent 2023; 14 (9):820-827.

DOI: 10.5005/jp-journals-10015-2294

License: CC BY-NC 4.0

Published Online: 13-10-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Aim: This research was conducted to analyze and compare the regenerative ability of 1% alendronate (ALN) and 1% metformin (MF) in chronic periodontitis patients with infrabony defects. Materials and methods: This study had a split-mouth design in which 26 sites with infrabony defects in chronic periodontitis patients were enrolled; 13 were aggregated to the group I (1% ALN gel) and 13 to group II (1% MF gel). A follow-up period of 3 and 6 months was observed postoperatively for the clinical parameters, and a follow-up of 6 months was observed radiologically, after which the data collected was analyzed. Results: Both groups demonstrated statistically significant probing pocket depth reduction, defect depth reduction (DDR), and relative attachment level gain at an interval of 6 months. However, no statistically significant distinction was observed among the groups in both clinical and radiographic measures, as well as crestal bone loss. Conclusion: Within the constraints of our study, no difference in the efficacy of 1% MF and 1% ALN was observed in periodontal therapy of chronic periodontitis patients with infrabony defects. Clinical significance: About 1% ALN and 1% MF have been shown to regenerate periodontal structures and, hence, can be used in the treatment of periodontitis, owing to their antiresorptive and bone-stimulating ability.

  1. Nazir MA. Prevalence of periodontal disease, its association with systemic diseases and prevention. Int J Health Sci (Qassim) 2017;11(2):72–80. PMID: 28539867.
  2. Fenesy KE. Periodontal disease: an overview for physicians. Mt Sinai J Med 1998;65(5-6):362–369. PMID: 9844364.
  3. Glossary of Periodontal terms. 4th edition. American Academy of Periodontology; 2001.
  4. Meyer JR. The regenerative potential of the periodontal ligament. J Prosthet Dent 1986;55(2):260–265. DOI: 10.1016/0022-3913(86)90357-4
  5. Sander L, Karring T. Healing of periodontal lesions in monkeys following the guided tissue regeneration procedure. A histological study. J Clin Periodontol 1995;22(4):332–337. DOI: 10.1111/j.1600-051x.1995.tb00156.x
  6. Ivanovic A, Nikou G, Miron RJ, et al. Which biomaterials may promote periodontal regeneration in intrabony periodontal defects? A systematic review of preclinical studies. Quintessence Int 2014;45(5):385–395. DOI: 10.3290/j.qi.a31538
  7. Rasmusson L, Abtahi J. Bisphosphonate associated osteonecrosis of the jaw: an update on pathophysiology, risk factors, and treatment. Int J Dent 2014;2014:471035. DOI: 10.1155/2014/471035
  8. Reddy GT, Kumar TM, Veena. Formulation and evaluation of alendronate sodium gel for the treatment of bone resorptive lesions in periodontitis. Drug Deliv 2005;12(4):217–222. DOI: 10.1080/10717540590952663
  9. Lin JH, Duggan DE, Chen IW, et al. Physiological disposition of alendronate, a potent anti-osteolytic bisphosphonate, in laboratory animals. Drug Metab Dispos 1991;19(5):926–932. PMID: 1686238.
  10. Jernberg GR, Jernberg, Gary R, assignee. Delivery of agents and method for regeneration of periodontal tissues. United States patent US 6,123,957. 2000.
  11. Sharma A, Raman A, Pradeep AR. Role of 1% alendronate gel as adjunct to mechanical therapy in the treatment of chronic periodontitis among smokers. J Appl Oral Sci 2017;25(3):243–249. DOI: 10.1590/1678-7757-2016-0201
  12. Sharma A, Pradeep AR. Clinical efficacy of 1% alendronate gel in adjunct to mechanotherapy in the treatment of aggressive periodontitis: a randomized controlled clinical trial. J Periodontol 2012;83(1):19–26. DOI: 10.1902/jop.2011.110206
  13. Carvalho Dutra B, Oliveira AMSD, Oliveira PAD, et al. Effects of topical application of 1% sodium alendronate gel in the surgical treatment of periodontal intrabony defects: a 6-month randomized controlled clinical trial. J Periodontol 2019;90(10):1079–1087. DOI: 10.1002/JPER.19-0160
  14. Pradeep AR, Rao NS, Naik SB, et al. Efficacy of varying concentrations of subgingivally delivered metformin in the treatment of chronic periodontitis: a randomized controlled clinical trial. J Periodontol 2013;84(2):212–220. DOI: 10.1902/jop.2012.120025
  15. Sculean A, Nikolidakis D, Nikou G, et al. Biomaterials for promoting periodontal regeneration in human intrabony defects: a systematic review. Periodontol 2000 2015;68(1):182–216. DOI: 10.1111/prd.12086
  16. Silness J, Loe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121–135. DOI: 10.3109/00016356408993968
  17. Löe H. The gingival index, the plaque index and the retention index systems. J Periodontol 1967;38(6):610–616. DOI: 10.1902/jop.1967.38.6.610
  18. Pihlstrom BL. Measurement of attachment level in clinical trials: probing methods. J Periodontol 1992;63(12 Suppl):1072–1077. DOI: 10.1902/jop.1992.63.12s.1072
  19. Kiliç AR, Efeoglu E, Yilmaz S. A new method for standardization of intraoral radiographs. Periodontal Clin Investig 1996;18(2):20–26. PMID: 9116467.
  20. Li G, Engström PE, Nasstrom K, et al. Marginal bone levels measured in film and digital radiographs corrected for attenuation and visual response: an in vivo study. Dentomaxillofac Radiol 2007;36(1):7–11. DOI: 10.1259/dmfr/28315324
  21. Mohapatra M, Parikh RK, Gohel MC. Formulation, development and evaluation of patient friendly dosage forms of metformin, part-II: oral soft gel. Asian J Pharm 2014;2(3):172–176. DOI: 10.22377/ajp.v2i3.207
  22. Westfelt E, Nyman S, Lindhe J, et al. Use of chlorhexidine as a plaque control measure following surgical treatment of periodontal disease. J Clin Periodontol 1983;10(1):22–36. DOI: 10.1111/j.1600-051x.1983.tb01264.x
  23. Sachs HA, Farnoush A, Checchi L, et al. Current status of periodontal dressings. J Periodontol 1984;55(12):689–696. DOI: 10.1902/jop.1984.55.12.689
  24. Heitz-Mayfield LJ, Lang NP. Surgical and nonsurgical periodontal therapy. Learned and unlearned concepts. Periodontol 2000 2013;62(1):218–231. DOI: 10.1111/prd.12008
  25. Bailey CJ. Metformin: historical overview. Diabetologia 2017;60(9):1566–1576. DOI: 10.1007/s00125-017-4318-z
  26. Bak EJ, Park HG, Kim M, et al. The effect of metformin on alveolar bone in ligature-induced periodontitis in rats: a pilot study. J Periodontol 2010;81(3):412–419. DOI: 10.1902/jop.2009.090414
  27. Kurian IG, Dileep P, Ipshita S, et al. Comparative evaluation of subgingivally-delivered 1% metformin and aloe vera gel in the treatment of intrabony defects in chronic periodontitis patients: a randomized, controlled clinical trial. J Investig Clin Dent 2018;9(3):e12324. DOI: 10.1111/jicd.12324
  28. Akram Z, Vohra F, Javed F. Locally delivered metformin as adjunct to scaling and root planing in the treatment of periodontal defects: A systematic review and meta-analysis. J Periodontal Res 2018;53(6):941–949. DOI: 10.1111/jre.12573
  29. Im GI, Qureshi SA, Kenney J, et al. Osteoblast proliferation and maturation by bisphosphonates. Biomaterials 2004;25(18):4105–4115. DOI: 10.1016/j.biomaterials.2003.11.024
  30. Chen J, Chen Q, Hu B, et al. Effectiveness of alendronate as an adjunct to scaling and root planing in the treatment of periodontitis: a meta-analysis of randomized controlled clinical trials. J Periodontal Implant Sci 2016;46(6):382–395. DOI: 10.5051/jpis.2016.46.6.382
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.